Ceapro

Ceapro — Investor Presentation (January 2016)

31 slides from Ceapro's investor presentation, January 2016

  1. Slide 1: Corporate Presentation

    Enhancing Life Through Nature Corporate Presentation January 2016 TSX: CZO www.ceapro.com

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements This presentation contains forward-looking statements. Various factors could cause actual results to differ materially from those projected in forward-looking statements, including those predicting the timing of product development and launches. Although the company believ

  3. Slide 3: Corporate Overview

    Corporate Overview Focused on the development and commercialization of active ingredients for healthcare and cosmetic industries - Unrivaled, proprietary plant extraction based manufacturing process Two active ingredients currently used in multiple household name products – cosmetics & personal care

  4. Slide 4: Core Expertise

    Core Expertise Identification, extraction and purification of active compounds from natural sources Create innovative ingredients for the personal and healthcare industries 4

  5. Slide 5: From Field to Formulation

    From Field to Formulation Field Research Manufacturing Consumer Identify Discover Develop Provide Novel Unique Functional Innovative Innovative Plants Actives Processes Products 5

  6. Slide 6: Unique Bioprocessing Expertise

    Unique Bioprocessing Expertise Ability to isolate and purify specific molecules from a wide range of botanical sources Prototype extracts are then prepared for bio-screening or in vivo testing Unique drying (heat-free) technology for sensitive compounds Commercialized unique bio-actives from several

  7. Slide 7: New & Innovative Technologies

    New & Innovative Technologies Pressurized Gas Expanded (PGX) Technology 7

  8. Slide 8: Proprietary Plant Extraction Based Manufacturing

    Proprietary Plant Extraction Based Manufacturing Lead Active Ingredients Beta Glucan Avenanthramides Lupinus angustifolia and Avena sativa 8

  9. Slide 9: Beta Glucan and Avenanthramides in Multiple Household Name Products

    Beta Glucan and Avenanthramides in Multiple Household Name Products Aveeno Coppertone Jergens Dove Lubriderm Burt’s Bees 3M – Nexcare The Body Shop KY Products Philosophy Neutrogena ROC 9

  10. Slide 10: Financial Performance 2012-2014

    Financial Performance 2012-2014 9,000 8,000 7,000 6,000 5,000 4,000 3,000 2,000 1,000 0 -1,000 2012 2013 2014 Revenue, $000 Income (loss) from operations, $000 10

  11. Slide 11: Opportunity to Expand into Multiple Markets

    Opportunity to Expand into Multiple Markets Cosmeceuticals Nutraceuticals Pharmaceuticals 11

  12. Slide 12: Fueling Our Pipeline

    Fueling Our Pipeline Pre-Clinical Clinical Market Beta Glucan Cosmetics and Personal Care Functional Drink Cholesterol Avenanthramides Cosmetics and Personal Care Exercised Induced Inflammation 12

  13. Slide 13: Beta Glucan

    Beta Glucan Beta glucan is a water soluble fibre found in the cell walls of oat kernels Acts as a natural moisture barrier and film-forming agent Relieves and alleviates dry and itchy skin by replenishing and protecting the skin’s moisture barrier Provides hydration against the drying effects of the

  14. Slide 14: Beta Glucan in Cosmeceuticals

    Beta Glucan in Cosmeceuticals Ceapro was the first to demonstrate that high molecular weight beta glucan can penetrate human skin Dermatology applications range from anti-ageing to wound healing New highly purified beta glucan powder successfully developed to address new market demands/trends 14

  15. Slide 15: Natural Skin Restructuring Agent

    Natural Skin Restructuring Agent Proven to effectively reduces fine lines & wrinkles Forms a natural barrier protecting skin Wound healing agent – films or gels Sustained release of active agents requiring enhanced percutaneous transportation 15

  16. Slide 16: Beta Glucan in Nutraceuticals and Pharmaceuticals

    Beta Glucan in Nutraceuticals and Pharmaceuticals Potential reduction of cardiovascular and heart diseases risk - Acts to decrease LDL and total cholesterol Proprietary beta glucan drug-delivery platform - Shown to effectively penetrate into the skin, into the deep layers as well as into the skin ce

  17. Slide 17: Unique Enabling Technology - PGX

    Unique Enabling Technology - PGX Pressurized Gas Expanded (PGX) Liquid – Spray Drying PGX is a novel spray drying technique for processing water-soluble biopolymers - Platform that can produce numerous morphologies of biopolymers ranging from fine fibres to granular powder, which are highly water so

  18. Slide 18: PGX-BG Impregnated with CoQ10 (iBG)

    PGX-BG Impregnated with CoQ10 (iBG) Impregnation of highly porous biopolymer matrix - with thermosensitive bioactives (or drugs, API) - Nutraceuticals - Functional food ingredients Pure PGX BG - Drug Delivery Vehicle Impregnation is accomplished - by means of supercritical CO2 - in the same processi

  19. Slide 19: CNC Before and After PGX Drying

    CNC Before and After PGX Drying Production of biomaterials from different industries 0.5 g CNC 0.5 g CNC Spray Dried PGX Dried CNC AEROGEL Density : 0.006 g/cm3 19

  20. Slide 20: Impregnation of PGX-GA with b-Carotene

    Impregnation of PGX-GA with b-Carotene 20

  21. Slide 21: PGX - A New Platform Technology

    PGX - A New Platform Technology Application of PGX-CNC - Wound healing, scaffolds - Drug delivery - Absorbents - Composite-plastic - Paints PGX processing allows processing of high value biopolymers - Beta Glucan - Chitosan - Gum Arabic - CNC 21

  22. Slide 22: Avenanthramides

    Avenanthramides Antihistamine and anti-inflammatory properties Potential benefits in the control of inflammation-based diseases 22

  23. Slide 23: Avenanthramides Clinically Proven in Cosmeceuticals

    Avenanthramides Clinically Proven in Cosmeceuticals Significant improvements in erythema symptoms associated in subjects with mild to moderate atopic dermatitis - 40% improvement in itch perception after 1 week - 62% of patients showed an improvement in their skin condition Subjects with atopy - 89%

  24. Slide 24: Advanced Skin Care

    Advanced Skin Care Skin inflammation is a complex physiological process Beta Glucan Beta glucan - Accelerates tissue healing - Deep hydrating agent - Improves elasticity - Natural film protective barrier Avenanthramides - Relief from itching (Pruritus) - Reduces inflammation and swelling - Reduces r

  25. Slide 25: Avenanthramides in Nutraceuticals and Pharmaceuticals

    Avenanthramides in Nutraceuticals and Pharmaceuticals Avenanthramides shown to attenuate exercise-induced inflammation in animal studies Human clinical studies showed that dietary avenanthramides supplements significantly reduced inflammation biomarkers in both elderly and young population New proce

  26. Slide 26: Strategy Designed to Leverage Enabling Technologies

    Strategy Designed to Leverage Enabling Technologies • Generate scientific data to support current product indications • Pursue new indications for current product portfolio from research programs • Develop new products in accordance with needs expressed by customers Cosmeceuticals • Improve manufact

  27. Slide 27: Value Drivers

    Value Drivers Cosmeceuticals - Current and new indications - Base business Nutraceuticals - New product development - Near term catalyst Pharmaceuticals - New products, new partnership discussions Manufacturing Innovation - New processes, higher output, lower cost 27

  28. Slide 28: New Bio-Processing Facility

    New Bio-Processing Facility R&D Pilot Scale Capability Commercial Production New 30,000 sq. ft. GMP Bio-processing Extraction Facility in Edmonton, Alberta, Canada 28

  29. Slide 29: Financial Profile

    Financial Profile TSX-V: CZO Stock Ticker $27.5M Market capitalization as of January 11, 2016 62.4M Common shares outstanding $7,233,000 Total sales for the nine-month period ending September 30, 2015 $5,000,000 Total amount of grant-based-funding raised to date 29

  30. Slide 30: Value-Driving Milestones

    Value-Driving Milestones Q1 2016 Q2 2016 Q3 2016 Q4 2016 Complete New Manufacturing Facility Complete Commercial Scale-up of PGX Sign PGX Alliance Opportunities Nutraceuticals and Pharmaceuticals Beta Glucan: Conduct Safety Studies of High Purity Beta Glucan in Oral Formulation Beta Glucan: Commence

  31. Slide 31: Enhancing Life Through Nature

    Enhancing Life Through Nature TSX: CZO www.ceapro.com

Ceapro — Investor Presentation (January 2016) on 6ix